Lisa Whitmyer, a nine-year survivor of ER+, early-stage breast cancer and a team leader in the commercial division of Biotheranostics, Inc. spends most of her waking hours educating physicians about Breast Cancer Index, a test that provides information on risk of recurrence and likelihood of benefit from extended anti-estrogen therapy for ER+, early-stage breast cancer patients.
Recently, Lisa’s found herself with limited free time, between her consuming professional career and training for the IRONMAN held in Lake Placid last weekend.